INVO Bioscience Probability of Future Stock Price Finishing Over 14.40
| INVODelisted Stock | USD 0.84 0.03 3.45% |
INVO |
INVO Bioscience Target Price Odds to finish over 14.40
The tendency of INVO Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 14.40 or more in 90 days |
| 0.84 | 90 days | 14.40 | close to zero percent |
Based on a normal probability distribution, the odds of INVO Bioscience to move over $ 14.40 or more in 90 days from now is close to zero percent (This INVO Bioscience probability density function shows the probability of INVO Stock to fall within a particular range of prices over 90 days) . Probability of INVO Bioscience price to stay between its current price of $ 0.84 and $ 14.40 at the end of the 90-day period is about 32.47 .
Given the investment horizon of 90 days INVO Bioscience has a beta of -0.85. This usually indicates Additionally INVO Bioscience has an alpha of 0.4998, implying that it can generate a 0.5 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). INVO Bioscience Price Density |
| Price |
Predictive Modules for INVO Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as INVO Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of INVO Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
INVO Bioscience Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. INVO Bioscience is not an exception. The market had few large corrections towards the INVO Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold INVO Bioscience, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of INVO Bioscience within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.50 | |
β | Beta against Dow Jones | -0.85 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | 0.02 |
INVO Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of INVO Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for INVO Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| INVO Bioscience is now traded under the symbol NAYA. Please update your portfolios or report it if you believe this is an error. Report It! | |
| INVO Bioscience is not yet fully synchronised with the market data | |
| INVO Bioscience is way too risky over 90 days horizon | |
| INVO Bioscience has some characteristics of a very speculative penny stock | |
| INVO Bioscience appears to be risky and price may revert if volatility continues | |
| INVO Bioscience has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 3.02 M. Net Loss for the year was (8.03 M) with profit before overhead, payroll, taxes, and interest of 535.27 K. | |
| INVO Bioscience currently holds about 1.96 M in cash with (4.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16. |
INVO Bioscience Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of INVO Stock often depends not only on the future outlook of the current and potential INVO Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. INVO Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.6 M | |
| Cash And Short Term Investments | 232.4 K |
INVO Bioscience Technical Analysis
INVO Bioscience's future price can be derived by breaking down and analyzing its technical indicators over time. INVO Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of INVO Bioscience. In general, you should focus on analyzing INVO Stock price patterns and their correlations with different microeconomic environments and drivers.
INVO Bioscience Predictive Forecast Models
INVO Bioscience's time-series forecasting models is one of many INVO Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary INVO Bioscience's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about INVO Bioscience
Checking the ongoing alerts about INVO Bioscience for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for INVO Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| INVO Bioscience is now traded under the symbol NAYA. Please update your portfolios or report it if you believe this is an error. Report It! | |
| INVO Bioscience is not yet fully synchronised with the market data | |
| INVO Bioscience is way too risky over 90 days horizon | |
| INVO Bioscience has some characteristics of a very speculative penny stock | |
| INVO Bioscience appears to be risky and price may revert if volatility continues | |
| INVO Bioscience has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 3.02 M. Net Loss for the year was (8.03 M) with profit before overhead, payroll, taxes, and interest of 535.27 K. | |
| INVO Bioscience currently holds about 1.96 M in cash with (4.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16. |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in INVO Stock
If you are still planning to invest in INVO Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Bioscience's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |